Back
Keyence Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
47
KYCCF
Keyence
Last Price:
417.41
Seasonality Move:
2.66%
Sell
13
AGIO
Agios Pharmaceuticals
Last Price:
46.27
Seasonality Move:
12.89%
Sell
47
Keyence (KYCCF)
is a Sell
Is Keyence a Buy, Sell or Hold?
- The current Keyence [KYCCF] share price is $433.00. The Score for KYCCF is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- KYCCF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
13
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
- The current Agios Pharmaceuticals [AGIO] share price is $46.02. The Score for AGIO is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
- AGIO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
KYCCF Stock Price Chart
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $46.02
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing selling pressure, which indicates risk of future bearish movement.
KYCCF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.63 | Sell |
| Relative Strength Index (14 RSI): | 49.51 | Sell |
| Chaikin Money Flow: | 803 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (417.99 - 443.03) | Buy |
| Bollinger Bands (100): | (425.15 - 471.75) | Sell |
AGIO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.87 | Buy |
| Relative Strength Index (14 RSI): | 34.55 | Sell |
| Chaikin Money Flow: | -1189890 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.88 - 60.12) | Sell |
| Bollinger Bands (100): | (42.24 - 53.22) | Sell |
KYCCF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 435.36 | Sell |
| 20-day SMA: | 426.26 | Buy |
| 50-day SMA: | 443.15 | Sell |
| 200-day SMA: | 450.61 | Sell |
| 8-day EMA: | 432.92 | Buy |
| 20-day EMA: | 432.63 | Buy |
| 50-day EMA: | 439.67 | Sell |
| 200-day EMA: | 445.7 | Sell |
AGIO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 56.48 | Sell |
| 20-day SMA: | 56.35 | Sell |
| 50-day SMA: | 49.77 | Sell |
| 200-day SMA: | 41.83 | Buy |
| 8-day EMA: | 54.42 | Sell |
| 20-day EMA: | 54.95 | Sell |
| 50-day EMA: | 51.77 | Sell |
| 200-day EMA: | 42.87 | Buy |
Keyence Earnings Growth & KYCCF Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
- Analysts estimate an earnings increase this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, an increase this year of $17.46 per share, and a decrease next year of $16.90 per share.
Keyence Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Agios Pharmaceuticals Technical Analysis
| Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 26 | 27 | 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||